Skip to main content
Log in

Bevacizumab

Metaphyseal bone lesions (first report) in an infant: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Smilth AR, Hennessy JM, Kurth MAH, Nelson SC.Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome. Pediatric Blood and Cancer 51: 418-420, No. 3, Sep 2008 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab. React. Wkly. 1217, 8 (2008). https://doi.org/10.2165/00128415-200812170-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812170-00023

Keywords

Navigation